Invesco’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $45.4M | Buy |
|
|||||
|
2025
Q2 | $36.4M | Sell |
|
|||||
|
2025
Q1 | $62.7M | Sell |
|
|||||
|
2024
Q4 | $130M | Buy |
|
|||||
|
2024
Q3 | $101M | Sell |
|
|||||
|
2024
Q2 | $173M | Buy |
|
|||||
|
2024
Q1 | $157M | Buy |
|
|||||
|
2023
Q4 | $88.8M | Buy |
|
|||||
|
2023
Q3 | $43.4M | Sell |
|
|||||
|
2023
Q2 | $53M | Sell |
|
|||||
|
2023
Q1 | $58.3M | Sell |
|
|||||
|
2022
Q4 | $170M | Buy |
|
|||||
|
2022
Q3 | $96.2M | Buy |
|
|||||
|
2022
Q2 | $26.4M | Buy |
|
|||||
|
2022
Q1 | $23.6M | Sell |
|
|||||
|
2021
Q4 | $23.9M | Sell |
|
|||||
|
2021
Q3 | $31.4M | Sell |
|
|||||
|
2021
Q2 | $106M | Buy |
|
|||||
|
2021
Q1 | $106M | Buy |
|
|||||
|
2020
Q4 | $104M | Sell |
|
|||||
|
2020
Q3 | $167M | Sell |
|
|||||
|
2020
Q2 | $238M | Buy |
|
|||||
|
2020
Q1 | $86M | Sell |
|
|||||
|
2019
Q4 | $120M | Sell |
|
|||||
|
2019
Q3 | $119M | Buy |
|
|||||
|
2019
Q2 | $108M | Sell |
|
|||||
|
2019
Q1 | $169M | Sell |
|
|||||
|
2018
Q4 | $152M | Sell |
|
|||||
|
2018
Q3 | $262M | Buy |
|
|||||
|
2018
Q2 | $204M | Sell |
|
|||||
|
2018
Q1 | $197M | Sell |
|
|||||
|
2017
Q4 | $211M | Sell |
|
|||||
|
2017
Q3 | $181M | Sell |
|
|||||
|
2017
Q2 | $136M | Buy |
|
|||||
|
2017
Q1 | $118M | Sell |
|
|||||
|
2016
Q4 | $108M | Buy |
|
|||||
|
2016
Q3 | $131M | Buy |
|
|||||
|
2016
Q2 | $72.9M | Sell |
|
|||||
|
2016
Q1 | $94.2M | Buy |
|
|||||
|
2015
Q4 | $110M | Sell |
|
|||||
|
2015
Q3 | $86.9M | Buy |
|
|||||
|
2015
Q2 | $98.7M | Buy |
|
|||||
|
2015
Q1 | $73M | Buy |
|
|||||
|
2014
Q4 | $3.38M | Buy |
|
|||||
|
2014
Q3 | $11K | Buy |
|
|||||
|
2014
Q2 | $10K | Hold |
|
|||||
|
2014
Q1 | $11K | Sell |
|
|||||
|
2013
Q4 | $7.6M | Buy |
|
|||||
|
2013
Q3 | $4.42M | Sell |
|
|||||
|
2013
Q2 | $5.23M | Buy |
|